References: Aminoglycoside dosing and administration

  • Avedissian SN, Rhodes NJ, Kim Y, Bradley J, Valdez JL, Le J. Augmented renal clearance of aminoglycosides using population-based pharmacokinetic modelling with Bayesian estimation in the paediatric ICU. J Antimicrob Chemother 2020;75(1):162-9. https://www.ncbi.nlm.nih.gov/pubmed/31648297
  • Avedissian SN, Rohani R, Bradley J, Le J, Rhodes NJ. Optimizing Aminoglycoside Dosing Regimens for Critically Ill Pediatric Patients with Augmented Renal Clearance: a Convergence of Parametric and Nonparametric Population Approaches. Antimicrob Agents Chemother 2021;65(4). https://www.ncbi.nlm.nih.gov/pubmed/33526481
  • Crcek M, Zdovc J, Kerec Kos M. A review of population pharmacokinetic models of gentamicin in paediatric patients. J Clin Pharm Ther 2019;44(5):659-74. https://www.ncbi.nlm.nih.gov/pubmed/31102287
  • Hartman SJF, Bruggemann RJ, Orriens L, Dia N, Schreuder MF, de Wildt SN. Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature. Clin Pharmacokinet 2020;59(2):173-205. https://www.ncbi.nlm.nih.gov/pubmed/31432468
  • Mahmoud SH, Shen C. Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing. Pharmaceutics 2017;9(3). https://www.ncbi.nlm.nih.gov/pubmed/28926966
  • Moffett BS, Kam C, Galati M, Schmees L, Stitt GA, Revell PA, et al. The "Ideal" Body Weight for Pediatric Gentamicin Dosing in the Era of Obesity: A Population Pharmacokinetic Analysis. Ther Drug Monit 2018;40(3):322-9. https://www.ncbi.nlm.nih.gov/pubmed/29521784
  • Pai MP, Nafziger AN, Bertino JS, Jr. Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients. Antimicrob Agents Chemother 2011;55(9):4006-11. https://www.ncbi.nlm.nih.gov/pubmed/21670189